Oct 2026· Medicine· Vol 105, pp. e50904· 0 citations· 47 references
Medicine
TL;DR
In conclusion, albumin is highlighted as a potential biomarker for nutritional-immunological interplay in allergic inflammation and support targeted nutritional strategies in at-risk pediatric populations through robustness across key subpopulations.
Abstract
While the association between serum albumin and eosinophils has been investigated in adult asthma, its role in any pediatric atopic triad – asthma, allergic rhinitis, or atopic dermatitis – remains unclear. We assessed the association between serum albumin and blood eosinophil counts in adolescents presenting with any atopic triad, using data from a 2-year National Health and Nutrition Examination Survey (NHANES) cycle. We analyzed data from 658 participants aged 12–18 years with any atopic triad condition from the 2005–2006 NHANES cycle. Multivariate linear regression models were employed to assess the potential association between serum albumin levels and blood eosinophil counts (BEOC). Trend tests, smooth curve fitting, and threshold effect models were applied to confirm this relationship, and stratified analyses were conducted to assess its consistency across subgroups. A significant negative association was observed between serum albumin and BEOC in the fully adjusted model (β = −0.08 × 103 cells/µL, 95% CI: −0.15, −0.01, P = .018). Moreover, curve fitting and threshold effect analyses confirmed a nonlinear relationship between serum albumin and BEOC, with an inflection point for threshold and saturation effects of 4.4 g/dL, beyond which the association attenuated. Stratified analyses confirmed robustness across key subpopulations. Our study identified a nonlinear association between serum albumin levels and BEOC in adolescents with any atopic triad, exhibiting an L-shaped relationship. These findings highlight albumin as a potential biomarker for nutritional-immunological interplay in allergic inflammation and support targeted nutritional strategies in at-risk pediatric populations.
Retinol-binding protein 4 (RBP4) has been linked to immune regulation, but whether its associations with type 2 inflammatory biomarkers (eosinophils and immunoglobulin E (IgE)) and pulmonary function differ by sex in asthma remains unknown. To evaluate the sex-specific associations of serum RBP4 with type 2 inflammator...
Rasha al-Darraji, Z. Al-Mudhafar· Egyptian Journal of Bronchol...· 0 citations
Background
Eosinophilic chronic obstructive pulmonary disease (COPD), is marked by type 2 inflammation, affects more than one-third of people with COPD, and is linked to exacerbation risk and corticosteroid responsiveness. The prevalence and clinical significance of allergic sensitization and elevated immunoglobulin E...
C. Denoncourt, M. Elfeshawy, Wen-Li Ni et al.· Chronic obstructive pulmonar...· 0 citations
Growing evidence links retinol binding protein-4 (RBP4) to inflammation; however, its association with inflammatory cell indices and spirometric parameters in asthma remains unclear, and the potential modifying role of ABO blood group has yet to be explored. The main aim was to assess the associations of serum RBP4 wit...
Rasha al-Darraji, Z. Al-Mudhafar· Monaldi archives for chest d...· 0 citations
Background: Asthma is a chronic inflammatory airway disease characterized by variable respiratory symptoms and reversible airflow limitation. Zinc, an essential trace element with antioxidant and immunomodulatory properties, may influence airway inflammation and asthma outcomes. This study evaluated serum zinc levels i...
Bhavani Binjawadagi, M. Savitha· International Journal of Con...· 0 citations
Background Atopic dermatitis (AD) is a chronic inflammatory skin disease that may involve systemic inflammation and metabolic disturbance. Serum albumin (Alb) is a routinely available negative acute-phase protein, but its association with hospitalized AD and sphingomyelin-related metabolic signals remains unclear. Meth...
Can-Ni Gao, Pei-Jia Zhang, Yi Yang et al.· Clinical, Cosmetic and Inves...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.